Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer - Concepedia

Concepedia

Publication | Closed Access

Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer

35

Citations

24

References

2018

Year

Glynn Weldon Gilcrease, David D. Stenehjem, Mark Wade, John R. Weis, Kimberly McGregor, Jonathan Whisenant, Kenneth M. Boucher, Kelli Thorne, Nicole Orgain, Ignacio Garrido‐Laguna,

Investigational New Drugs

First–line TreatmentOncologyGastrointestinal OncologyPhase I/ii StudyMedicinePathologyColorectal CancerMetastatic Colorectal CancerCancer TreatmentPharmacologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1